Alloclamide

Alloclamide

Clinical data
Trade names	Pectex, Tuselin
Identifiers
IUPAC name 2-(Allyloxy)-4-chloro-N-[2-(diethylamino)ethyl]benzamide
CAS Number	5486-77-1 Y
PubChem CID	71837
ChemSpider	64859
UNII	H7B263Z7AQ
KEGG	D01524
ChEBI	CHEBI:135326
ChEMBL	ChEMBL2103989
CompTox Dashboard (EPA)	DTXSID9048853
Chemical and physical data
Formula	C16H23ClN2O2
Molar mass	310.82 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCN(CC)CCNC(=O)C1=C(C=C(C=C1)Cl)OCC=C
InChI InChI=1S/C16H23ClN2O2/c1-4-11-21-15-12-13(17)7-8-14(15)16(20)18-9-10-19(5-2)6-3/h4,7-8,12H,1,5-6,9-11H2,2-3H3,(H,18,20) Key:UHWFVIPXDFZTFA-UHFFFAOYSA-N

Alloclamide (Pectex, Tuselin) is an antitussive and antihistamine drug marketed in Finland and Spain. It has never been marketed in the US.

It is sold as an oral solution, containing 6.25 mg/mL alloclamide. The recommended dosage for adults is 25 mg three to four times daily. Adverse effects include constipation and sedation.^[1]

References

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

• v
• t
• e

This page was last edited on 14 February 2024, at 18:28